Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1295-2023Class II

PCRopsis BCSNano (1mL), REF 2276001; nucleic acid extraction from a variety of biological samples

Entopsis, Inc. / initiated 2023-02-21 / Open, Classified / root cause: labeling and UDI

Entopsis , Inc. began a recall of PCRopsis BCSNano (1mL), REF 2276001; nucleic acid extraction from a variety of biological samples on . FDA classified it as Class II and gives the reason as "Presence of misleading label statements on the product label". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1295-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Entopsis, Inc.
Product
PCRopsis BCSNano (1mL), REF 2276001; nucleic acid extraction from a variety of biological samples
Product code
JJH Clinical Sample Concentrator
Reason for recall
Presence of misleading label statements on the product label.
Root cause tag
labeling and UDI
FDA root cause
Under Investigation by firm
Action
The firm issued a MEDICAL DEVICE RECALL notice to its consignees on 02/21/22023 by email. Those without a valid email address were mailed the notice via certified mail. The notice explained the issue and risk and requested the customer/user take the following actions: "Entopsis Inc., requests that the product lots listed below - shipped/received before February 8st, 2023 be promptly discontinued from use and discarded from inventory as per your non-hazardous waste disposal plan.The labeling of PCRopsis products was revised on February 8th, 2022. Updated statements of intended use and revised instructions for use are available on www.pcropsis.com. If you are currently using or intend to use the PCRopsis product lots affected by this recall please contact us at [email protected] or 1-888-407-5070 (Monday to Friday 9.00 AM to 4.30 PM Eastern Time) to request a replacement. If you are a re-distributor of PCRopsis devices, notify your end customer with a copy of this letter. Please acknowledge the removal of affected product lots by filling out the attached acknowledgment form and returning it to us at [email protected]. Contact us at [email protected] or 1-888-407-5070 - Monday to Friday 9.00 AM to 4.30 PM US Eastern Time (GMT -5) with any questions you may have."
Quantity in commerce
3 units
Distribution
Nationwide and Canada, UK, Portugal, England, Spain, England , Germany, Brazil, Denmark, KOR, South Korea, Colombia, Lithuania
Product codes and lots
Lot number 3, Exp. 11/2023

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1295-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1295-2023Class IIOngoingVoluntary: Firm initiated
Z-1296-2023Class IIOngoingVoluntary: Firm initiated
Z-1297-2023Class IIOngoingVoluntary: Firm initiated
Z-1298-2023Class IIOngoingVoluntary: Firm initiated
Z-1299-2023Class IIOngoingVoluntary: Firm initiated
Z-1300-2023Class IIOngoingVoluntary: Firm initiated
Z-1301-2023Class IIOngoingVoluntary: Firm initiated